Barrett esophagus Therapy
Educational only: videos on MedicalVideos.com are for general information and are not medical advice. Always consult your own doctor about your health.
Barrett's esophagus is a complication of chronic (long lasting) and usually severe gastrointestinal reflux disease (GERD), but occurs in only a small percentage of patients with GERD. Criteria are needed for screening patients with GERD for Barrett's esophagus. Until validated criteria are available, it seems reasonable to do screening endoscopies in GERD patients who cannot be taken off acid suppression therapy after two to three years. The diagnosis of Barrett's esophagus rests upon seeing (at endoscopy) a pink esophageal lining that extends a short distance (usually less than 2.5 inches) up the esophagus from the gastroesophageal junction and finding intestinal type cells (goblet cells) on biopsy of the lining. There is a small but definite increased risk of cancer of the esophagus (adenocarcinoma) in patients with Barrett's esophagus.
This video in 30 seconds
This video covers Barrett's esophagus, described as a complication of chronic, severe gastroesophageal reflux disease (GERD). It discusses screening endoscopy in GERD patients, diagnosis by endoscopy appearance and biopsy finding intestinal type goblet cells, and the increased risk of esophageal adenocarcinoma.
Key points
- Barrett's esophagus is described as a complication of chronic GERD
- Screening endoscopy in GERD patients who cannot stop acid suppression is discussed
- Diagnosis by endoscopic appearance and biopsy goblet cells is covered
- Increased risk of esophageal adenocarcinoma is described
Medical Videos
Free medical and surgery videos for patients, students and professionals — trusted since 2007.
Founded by Dr. Mohamed Ibrahim, MD, PhD — physician-scientist.
Follow us on Facebook · Instagram
SORT BY-
Top Comments
-
Latest comments